Cargando…
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
BACKGROUND: Recent studies have shown that microRNAs may regulate the ABCB1 gene (ATP-binding cassette, sub-family B [MDR/TAP], member 1). Computational programs have predicted that the 3’-untranslated region (3’-UTR) of ABCB1 contains a potential miRNA-binding site for miR-186. Here, we investigate...
Autores principales: | Sun, Kai-Xuan, Jiao, Jin-Wen, Chen, Shuo, Liu, Bo-Liang, Zhao, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667519/ https://www.ncbi.nlm.nih.gov/pubmed/26626440 http://dx.doi.org/10.1186/s13048-015-0207-6 |
Ejemplares similares
-
MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016) -
MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016) -
Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9
por: Gong, Jian-Ping, et al.
Publicado: (2016) -
MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs
por: Chen, Shuo, et al.
Publicado: (2015) -
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
por: Gao, Bo, et al.
Publicado: (2014)